Possible Neurophysiological Markers of Early Neurodegenerative Process: Parkinson’s Disease

被引:0
|
作者
B. Kh. Baziyan
机构
[1] Russian Academy of Medical Sciences,Laboratory of Neurocybernetics, Research Center of Neurology
关键词
Parkinson’s disease; eye, head, and hand movements; coordination; neurophysiological markers; neurodegenerative processes;
D O I
暂无
中图分类号
学科分类号
摘要
We used tests for evaluation of latent period, duration, and accuracy of eyes, head, or hand movements and their coordinated movements. Comparative analysis of these parameters was performed in healthy subjects and in patients with early stages of Parkinson’s disease. The pathology data significantly (p<0.05) differed from those in normal control subjects. These results can be used as neurophysiological markers of early neurodegenerative process. Increasing the number of tests would lead to better specificity of the markers. It will be possible to create a battery of neurophysiological tests most likely reflecting the predictive basis of early neurodegenerative process.
引用
收藏
页码:186 / 188
页数:2
相关论文
共 50 条
  • [1] Possible Neurophysiological Markers of Early Neurodegenerative Process: Parkinson's Disease
    Baziyan, B. Kh.
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 2012, 154 (02) : 186 - 188
  • [2] Neurophysiological markers of motor compensatory mechanisms in early Parkinson's disease
    Passaretti, Massimiliano
    Cilia, Roberto
    Rinaldo, Sara
    Sebastiano, Davide Rossi
    Orunesu, Eva
    Devigili, Grazia
    Braccia, Arianna
    Paparella, Giulia
    De Riggi, Martina
    van Eimeren, Thilo
    Strafella, Antonio Paolo
    Lanteri, Paola
    Berardelli, Alfredo
    Bologna, Matteo
    Eleopra, Roberto
    BRAIN, 2024, 147 (11) : 3714 - 3726
  • [3] Possible Early Markers of Parkinson's Disease (PD)
    Gelpey, M.
    Goncharova, Z.
    Oksenjuk, O.
    Tanova, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 882 - 882
  • [4] Neurophysiological markers of motor reserve in Parkinson's disease
    Passaretti, M.
    Rinaldo, S.
    Orunesu, E.
    Sebastiano, D. Rossi
    De Vigili, G.
    Barbiera, G.
    Braccia, A.
    Paparella, G.
    De Riggi, M.
    Lanteri, P.
    Berardelli, A.
    Strafella, A. P.
    Bologna, M.
    Eleopra, R.
    Cilia, R.
    MOVEMENT DISORDERS, 2023, 38 : S543 - S543
  • [5] Myeloperoxidase in the neurodegenerative process of Parkinson's disease
    Teismann, P.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2014, 139 (03) : 99 - 102
  • [6] Possible neurophysiological markers of genetic predisposition to Alzheimer's disease
    Ponomareva, NV
    Fokin, VF
    Selesneva, ND
    Voskresenskaia, NI
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 1998, 9 (05) : 267 - 273
  • [7] The role of amylin in Parkinson′s disease neurodegenerative process
    Bugallo, R.
    Martinez-Valbuena, I.
    Marcilla, I.
    Caballero, M. C.
    Vilas-Zornoza, A.
    Guruceaga, E.
    Sanchez-Arias, A.
    Ursua, S.
    Perez-Mediavilla, A.
    Luquin, M. R.
    MOVEMENT DISORDERS, 2021, 36 : S330 - S331
  • [8] Is neuroprotection possible in Parkinson's disease and other neurodegenerative diseases?
    Youdim, M
    NEUROPROTECTION AND NEURODEGENERATION IN PARKINSON'S DISEASE, 2000, (71): : 17 - 24
  • [9] THE PROFILE OF CSF NEURODEGENERATIVE MARKERS IN DIFFERENT PHENOTYPES OF PARKINSON'S DISEASE
    Vranova, H. Prikrylova
    Mares, J.
    Hlustik, P.
    Nevrly, M.
    Stejskal, D.
    Zapletalova, J.
    Obereigneru, R.
    Kanovsky, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 236 - 236
  • [10] Neurodegenerative markers in CSF in patients suffering from Parkinson's disease
    Vranova, H.
    Nevrly, M.
    Mares, J.
    Stejskal, D.
    Kanovsky, P.
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S186 - S186